Literature DB >> 18587053

The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice.

Quanfu Mao1, Sravanthi Gundavarapu, Chintan Patel, Amy Tsai, Francois I Luks, Monique E De Paepe.   

Abstract

The functional significance of the Fas/Fas-ligand (FasL) system in hyperoxia-induced lung injury and alveolar disruption in newborn lungs in vivo remains undetermined. To assess the role of the Fas/FasL system, we compared the effects of hyperoxia (95% O2 from birth to Postnatal Day [P]7) in Fas-deficient lpr mice and wild-type mice. Alveolar disruption was more severe in hyperoxic lpr mice than in wild-type mice. In addition, a transient alveolarization defect was noted in normoxic lpr mice. Hyperoxia induced marked up-regulation of pulmonary Fas expression in wild-type mice, as well as elevated mRNA levels of pro-apoptotic Bax, Bad, and Bak. Pulmonary apoptotic activity was similar in hyperoxic wild-type and lpr mice. In contrast, lung growth and proliferation, assessed by stereologic volumetry and Ki67 proliferation studies, were significantly higher in hyperoxic wild-type mice compared with lpr mice, suggesting the Fas/FasL system has a pro-proliferative role in hyperoxic conditions. Levels of the prosurvival MAPkinase, pERK1/2, were significantly higher in hyperoxic wild-type mice compared with lpr mice, while pAkt levels were similar. These data suggest that the primary role of the Fas/FasL system in hyperoxic newborn lungs is pro-proliferative, rather than pro-apoptotic, and likely mediated through a Fas-ERK1/2 pathway. Fas-induced proliferation and lung growth in hyperoxic newborn lungs may counteract, in part, the detrimental effects of apoptosis mediated by non-Fas pathways, such as pro-apoptotic Bax/Bcl-2 family members. The capacity of the Fas/FasL signaling pathway to mediate protective rather than destructive functions in hyperoxic newborn lungs highlights the versatility of this complex pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587053      PMCID: PMC2586047          DOI: 10.1165/rcmb.2008-0052OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  68 in total

1.  Fas engagement accelerates liver regeneration after partial hepatectomy.

Authors:  J Desbarats; M K Newell
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

2.  Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia.

Authors:  K Kuwano; M Kawasaki; T Maeyama; N Hagimoto; N Nakamura; K Shirakawa; N Hara
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

3.  The CD95 receptor: apoptosis revisited.

Authors:  Marcus E Peter; Ralph C Budd; Julie Desbarats; Stephen M Hedrick; Anne-Odile Hueber; M Karen Newell; Laurie B Owen; Richard M Pope; Juerg Tschopp; Harald Wajant; David Wallach; Robert H Wiltrout; Martin Zörnig; David H Lynch
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

4.  Regulation of apoptosis and T cell activation by Fas-specific mAb.

Authors:  M R Alderson; T W Tough; S Braddy; T Davis-Smith; E Roux; K Schooley; R E Miller; D H Lynch
Journal:  Int Immunol       Date:  1994-11       Impact factor: 4.823

Review 5.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

6.  Growth of pulmonary microvasculature in ventilated preterm infants.

Authors:  Monique E De Paepe; Quanfu Mao; Jessica Powell; Sam E Rubin; Philip DeKoninck; Naomi Appel; Meredith Dixon; Füsun Gundogan
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

7.  Fas ligand expression coincides with alveolar cell apoptosis in late-gestation fetal lung development.

Authors:  M E De Paepe; L P Rubin; C Jude; A M Lesieur-Brooks; D R Mills; F I Luks
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

8.  Interleukin-6-induced protection in hyperoxic acute lung injury.

Authors:  N S Ward; A B Waxman; R J Homer; L L Mantell; O Einarsson; Y Du; J A Elias
Journal:  Am J Respir Cell Mol Biol       Date:  2000-05       Impact factor: 6.914

9.  ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2.

Authors:  S Buckley; B Driscoll; L Barsky; K Weinberg; K Anderson; D Warburton
Journal:  Am J Physiol       Date:  1999-07

Review 10.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

View more
  7 in total

1.  Interactive and independent effects of early lipopolysaccharide and hyperoxia exposure on developing murine lungs.

Authors:  Amrit Kumar Shrestha; Renuka T Menon; Ahmed El-Saie; Roberto Barrios; Corey Reynolds; Binoy Shivanna
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-09       Impact factor: 5.464

2.  Effects of Fas-ligand overexpression on alveolar type II cell growth kinetics in perinatal murine lungs.

Authors:  Monique E de Paepe; Sheila A Haley; Zacharie Lacourse; Quanfu Mao
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

3.  beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia.

Authors:  Anna Hogmalm; Dean Sheppard; Urpo Lappalainen; Kristina Bry
Journal:  Am J Respir Cell Mol Biol       Date:  2009-08-28       Impact factor: 6.914

Review 4.  Oxidative stress diseases unique to the perinatal period: A window into the developing innate immune response.

Authors:  Robert M Dietz; Clyde J Wright
Journal:  Am J Reprod Immunol       Date:  2017-11-30       Impact factor: 3.886

5.  Probucol attenuates hyperoxia-induced lung injury in mice.

Authors:  Tomonobu Kawaguchi; Toyoshi Yanagihara; Tetsuya Yokoyama; Saiko Suetsugu-Ogata; Naoki Hamada; Chika Harada-Ikeda; Kunihiro Suzuki; Takashige Maeyama; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

6.  Hyperoxia Disrupts Extracellular Signal-Regulated Kinases 1/2-Induced Angiogenesis in the Developing Lungs.

Authors:  Renuka T Menon; Amrit Kumar Shrestha; Roberto Barrios; Binoy Shivanna
Journal:  Int J Mol Sci       Date:  2018-05-20       Impact factor: 5.923

7.  TRAIL protects the immature lung from hyperoxic injury.

Authors:  Tayyab Shahzad; Cho-Ming Chao; Stefan Hadzic; Judith Behnke; Luisa Biebach; Eva Böttcher-Friebertshäuser; Jochen Wilhelm; Anne Hilgendorff; Klaus-Peter Zimmer; Rory E Morty; Saverio Bellusci; Harald Ehrhardt
Journal:  Cell Death Dis       Date:  2022-07-15       Impact factor: 9.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.